Zoetis Inc (ZTS) will raise its quarterly dividend by 14.5 percent to $0.095 per share. The Pfizer spin-off has now raised its dividend for three consecutive years since a quarterly dividend was initiated in 2013.
Zoetis Inc. is an animal health company. Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals worldwide. The company, formerly a subsidiary of Pfizer, went public in 2013 and has paid a dividend ever since.